Literature DB >> 14675588

Circulating matrix metalloproteinase-1 and -3 in patients with an acute coronary syndrome.

Teruo Inoue1, Toru Kato, Kan Takayanagi, Toshihiko Uchida, Isao Yaguchi, Hirotoshi Kamishirado, Shigenori Morooka, Nobuo Yoshimoto.   

Abstract

To elucidate the diagnostic value of serum matrix metalloproteinase (MMP) levels, we measured MMP-1 and MMP-3 by a 1-step sandwich enzyme immunoassay. The transcardiac gradients of both MMPs were greater in patients with unstable angina and acute myocardial infarction than in patients with stable effort angina or control patients. Serum MMP levels appear to be a marker of plaque instability in patients with acute coronary syndrome.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14675588     DOI： 10.1016/j.amjcard.2003.08.061

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  11 in total

Review 1.  The role of matrix metalloproteinases in atherothrombosis.

Authors:  Daniel F J Ketelhuth; Magnus Bäck
Journal:  Curr Atheroscler Rep       Date:  2011-04       Impact factor: 5.113

2.  Noncanonical Matrix Metalloprotease 1-Protease-Activated Receptor 1 Signaling Drives Progression of Atherosclerosis.

Authors:  Rajashree Rana; Tianfang Huang; Georgios Koukos; Elizabeth K Fletcher; Susan E Turner; Andrew Shearer; Paul A Gurbel; Jeffrey J Rade; Carey D Kimmelstiel; Kevin P Bliden; Lidija Covic; Athan Kuliopulos
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-04-05       Impact factor: 8.311

3.  The Role of Matrix Metalloproteinase-3 In the Development of Atherosclerosis and Cardiovascular Events.

Authors:  Krintus Magdalena; Kuligowska Magdalena; Sypniewska Grazyna
Journal:  EJIFCC       Date:  2006-03-20

4.  Matrix metalloproteinases and cardiovascular diseases.

Authors:  A Papazafiropoulou; N Tentolouris
Journal:  Hippokratia       Date:  2009-04       Impact factor: 0.471

5.  Rosuvastatin therapy does not affect serum MMP-13 or TIMP-1 levels in hypercholesterolemic patients.

Authors:  Cihan Cevik; Kenneth Nugent; Gary Meyerrose; Mohammad Otahbachi; Cemil Izgi; Mark Lyte; R David Fish
Journal:  Tex Heart Inst J       Date:  2011

6.  Omentin concentrations are independently associated with those of matrix metalloproteinase-3 in patients with mild but not severe rheumatoid arthritis.

Authors:  Chanel Robinson; Linda Tsang; Ahmed Solomon; Angela J Woodiwiss; Sule Gunter; Aletta M E Millen; Gavin R Norton; Maria J Fernandez-Lopez; Ivana Hollan; Patrick H Dessein
Journal:  Rheumatol Int       Date:  2016-07-30       Impact factor: 2.631

Review 7.  Myocardial remodeling: cellular and extracellular events and targets.

Authors:  Jennifer A Dixon; Francis G Spinale
Journal:  Annu Rev Physiol       Date:  2011       Impact factor: 19.318

8.  Simultaneous consideration of multiple candidate protein biomarkers for long-term risk for cardiovascular events.

Authors:  Sharif A Halim; Megan L Neely; Karen S Pieper; Svati H Shah; William E Kraus; Elizabeth R Hauser; Robert M Califf; Christopher B Granger; L Kristin Newby
Journal:  Circ Cardiovasc Genet       Date:  2014-11-24

9.  Genome-wide association scan identifies variants near Matrix Metalloproteinase (MMP) genes on chromosome 11q21-22 strongly associated with serum MMP-1 levels.

Authors:  Yu-Ching Cheng; Wen-Hong L Kao; Braxton D Mitchell; Jeffrey R O'Connell; Haiqing Shen; Patrick F McArdle; Quince Gibson; Kathleen A Ryan; Alan R Shuldiner; Toni I Pollin
Journal:  Circ Cardiovasc Genet       Date:  2009-05-14

10.  MMP-1 serum levels predict coronary atherosclerosis in humans.

Authors:  Michael Lehrke; Martin Greif; Uli C Broedl; Corinna Lebherz; Rüdiger P Laubender; Alexander Becker; Franz von Ziegler; Janine Tittus; Maximilian Reiser; Christoph Becker; Burkhard Göke; Gerhard Steinbeck; Alexander W Leber; Klaus G Parhofer
Journal:  Cardiovasc Diabetol       Date:  2009-09-14       Impact factor: 9.951
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.